Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Abdi Mohit

Neurological Surgery Cleveland, OH Medical Doctor

NPI 1174622831 CMS profile 189837

Cleveland Clinic Spine Institute, 9500 Euclid Ave-A41, Cleveland, OH 44195

Open in the dashboard

General payments

$884,045

192 records reported · program years 2019–2025

Research payments

$1,650

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Abdi Mohit of Cleveland, OH is reported in the CMS Open Payments database as having received $884,045 across 192 general payments and $1,650 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $142,980 8
2024 General $109,515 22
2023 General $152,341 14
2023 Research $1,100 1
2022 General $142,959 35
2021 General $133,578 32
2020 General $100,624 39
2020 Research $550 1
2019 General $102,048 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Abdi Mohit
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Abdi Mohit were reported at $142,980. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Abdi Mohit Neurological Surgery median Middle half National median
2019 $102,048 $582 $138–$3,006 $163
2020 $100,624 $294 $76–$2,174 $114
2021 $133,578 $387 $105–$2,432 $132
2022 $142,959 $542 $139–$2,989 $149
2023 $152,341 $534 $145–$2,697 $160
2024 $109,515 $574 $155–$3,046 $164
2025 $142,980 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $841,463 32 payments
  2. Seaspine Orthopedics Corporation $22,735 53 payments
  3. Orthofix Medical, Inc. $11,663 13 payments
  4. Stryker Corporation $2,944 11 payments
  5. Nevro Corp. $2,536 40 payments
  6. Alphatec Spine, Inc $897 7 payments
  7. SI-BONE, Inc. $474 4 payments
  8. Medtronic, Inc. $284 4 payments
  9. Medtronic USA, Inc. $264 7 payments
  10. DePuy Synthes Sales Inc. $264 3 payments
  11. Other $520 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $841,056 24 payments
  2. Consulting Fee $29,950 20 payments
  3. Travel and Lodging $7,879 43 payments
  4. Food and Beverage $5,160 105 payments
Products named General payments · program years 2019–2025
  1. QUARTEX Spine $328,010 9 payments
  2. QUARTEX Spine/Spine Surgery $252,900 8 payments
  3. QUARTEX Spine/Spine Surgery $139,236 4 payments
  4. QUARTEX Spine/Joint $120,950 4 payments
  5. WaveForm TA $17,470 17 payments
  6. Reef TA $13,849 12 payments
  7. WaveForm TO $12,750 4 payments
  8. Reef TO $9,125 3 payments
  9. Mariner Deformity $4,375 3 payments
  10. Mariner MCT $3,625 1 payment
  11. Other $17,377 126 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Carbofix Spine Inc $1,650 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

141

Median for Neurosurgery: 83

Drug cost

$962

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dexamethasone Generic 51 $331
Gabapentin Generic 37 $233
Methocarbamol Generic 21 $184
Meloxicam Generic 17 $123
Methylprednisolone Generic 15 $90

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$263,466

Medicare's payments for the services billed

Medicare patients

275

Average age 74

Services billed

922

140 women, 135 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Depression 25%
Diabetes 23%
Ischemic heart disease 22%
Chronic kidney disease 20%
Osteoporosis 19%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

194 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record